| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.3 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.3 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |